Aurobindo Pharma to expand footprint in Europe: Report

22 Feb 2016 Evaluate

Aurobindo Pharma is reportedly planning to expand its footprint in newer markets in the European Union. The Hyderabad-based company intends to consolidate its position and presence among the top 10 companies in Europe.

The proposed expansion will not just be in new markets such as Poland and Czech Republic, but there will also be portfolio expansion through targeted first day launches in orals, hormonals, penems, oncology drugs and niche injectables, among others, according to the information shared in its latest investor presentation.

Aurobindo Pharma Share Price

1175.10 6.20 (0.53%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1311.75
Zydus Lifesciences 879.25
Lupin 2128.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×